| Name | Title | Contact Details |
|---|---|---|
Harry Sidhu |
Finance Director, North America Commercial | Profile |
Pamela Duffy |
Director, CMO Vendor Management | Profile |
Titus Ball |
Vice President and Chief Accounting Officer | Profile |
Jennifer Chang |
Director Talent Development | Profile |
Julius Pryor |
Global Head of Diversity and Health Equity | Profile |
Cellnetix is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We are a clinical-stage biopharmaceutical company focused on changing the lives of patients living with nonalcoholic steatohepatitis (NASH) and other liver and metabolic disorders. Our teams in the US and Israel are developing highly differentiated medicines that address unmet medical needs based on robust research. Our lead product candidate, BIO89-100, is a novel long-acting glycopegylated fibroblast growth factor 21 (FGF21) analogue.
Delix Therapeutics is applying modern tools of pharmaceutical development to some of natures most ancient therapies, psychedelics.
20/20 GeneSystems Inc is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Checkerspot is a design-centric materials company enabling ultra-high performance consumer products.